Blendis L M, Greig P D, Langer B, Baigrie R S, Ruse J, Taylor B R
Gastroenterology. 1979 Aug;77(2):250-7.
Fifteen patients with chronic liver disease having a peritoneovenous shunt for chronic intractable ascites were studied prospectively for renal function and hemodynamic changes during balance studies, pre-, peri-, and postoperatively. Shunt insertion caused a rapid redistribution of ascites into the intravascular compartment with hemodilution and significant rises in cardiac output (9 patients) (P less than 0.025) renal blood flow (3 patients) (P less than 0.025), and creatinine clearance (15 patients) (P less than 0.005), and decreases in plasma renin activity (10 patients) and serum aldosterone levels (9 patients) (P less than 0.025). Despite these changes, small repeated doses of furosemide were required to start and maintain a diuresis and natriuresis with sodium excretion rising from 7.2 +/- 4.1 to 174 +/- 44 meq/day (P less than 0.0005) in the 15 patients. At 2 wk postoperatively, the 15 patients had lost a mean of 7.5 kg in weight associated with a persistent improvement in creatinine clearance and a continued natriuresis, 15.9 +/- 7 mEq/day (P less than 0.005), despite no statistically significant change in cardiac output (7 patients) or renal blood flow (4 patients) compared with preoperative levels. This operation is an effective therapy for refractive ascites, but the incidence of potentially fatal complications makes us hesitate to recommend it except for patients resistant to normal conservative measures.
对15例患有慢性肝病并因慢性顽固性腹水而进行腹腔静脉分流术的患者,在术前、术中和术后的平衡研究期间,对其肾功能和血流动力学变化进行了前瞻性研究。分流术导致腹水迅速重新分布到血管内间隙,伴有血液稀释,心输出量(9例患者)显著增加(P<0.025),肾血流量(3例患者)增加(P<0.025),肌酐清除率(15例患者)增加(P<0.005),血浆肾素活性(10例患者)和血清醛固酮水平(9例患者)降低(P<0.025)。尽管有这些变化,但仍需要小剂量重复使用呋塞米来启动和维持利尿和利钠作用,15例患者的钠排泄量从7.2±4.1增加到174±44 meq/天(P<0.0005)。术后2周时,15例患者平均体重减轻7.5 kg,肌酐清除率持续改善,利钠作用持续存在,为15.9±7 mEq/天(P<0.005),尽管与术前水平相比,心输出量(7例患者)或肾血流量(4例患者)无统计学显著变化。该手术是治疗难治性腹水的有效方法,但潜在致命并发症的发生率使我们在除对常规保守措施耐药的患者外,对推荐该手术犹豫不决。